In Depth 21 Aug 2024
The promise of antisense oligonucleotides in precision medicine
Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases.
Drug development
- Latest Posts
Podcast 2 Aug 2024
Rebroadcast: How does AI assist drug discovery?
Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS.
In Depth 10 Jul 2024
Biotech’s battle against skeletal dysplasia: Ray of hope for children with rare genetic disorder
As treatments for skeletal dysplasia are intended to alleviate painful symptoms, two drugs are battling out in the clinic to prove their effectiveness.
In Depth 4 Jul 2024
Parkinson’s disease: biotech’s pursuit for more therapies
Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store?
Powering up biologics development using mammalian cell lines
Explore how mammalian cell lines drive biopharmaceutical innovation, acting as mini-factories for vital biotherapeutics and vaccines.
In Depth 13 Mar 2024
From LSD to healing minds: Where are we standing in psychedelic drug development?
Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field.
ADVERTISEMENT
ADVERTISEMENT
In Depth 21 Feb 2024
Cytokine release syndrome: how pharma is tackling a 21st century disease
Explore the frontier of biotech’s battle against cytokine release syndrome (CRS), from historical setbacks to cutting-edge solutions.
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
Podcast 16 Feb 2024
How does AI help drug discovery?
Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” cancer targets like KRAS.
How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases
Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.
Best in Biotech 5 Jan 2024
Five AI drug discovery companies you should know about
Take a look at five of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
Opinion 29 Nov 2023
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be approved for clinical use. For any pharmaceutical company or academic institution, it is a big achievement to advance a drug candidate […]
ADVERTISEMENT